The European Brain Council and beLean.net launch the first ever Brain Innovation Days, set to launch virtually on 13 October 2020, kicking off one full year of a packed brain innovation agenda. 

 
This lunchtime interactive session will fall under the overarching theme, “Disrupt and rewire: How brain innovation is changing Europe” and will bring together representatives from the European Commission, the European Medicines Agency, the Innovative Medicines Initiative and the European Parliament alongside key opinion leaders, researchers, start-ups, clinicians and more to explore and answer the question: why is brain innovation important and how is it changing Europe and the world? 

The event will be opened by EBC President, Monica Di Luca and Jean-Eric Paquet, Director-General of the Directorate-General for Research and Innovation at the European Commission. The entire programme and the list of speakers can be found here. 

179 million Europeans are currently living with brain disorders and this is to steadily increase as the population ages. Though one in three Europeans are set to live with a brain disease at some point of their life, neurological and mental alike.  In addition, it is estimated that brain disorders account for up to 45% of total healthcare budgets and this burden is expected to grow. Despite the prevalence of brain disorders in Europe, there is currently no disease modifying treatment available to cure a wide range of mental and neurological conditions. Developing treatments that can significantly improve the lives of those living with brain disorders is extremely challenging. Yet, compared to other disease areas, the pace of innovation in this field has traditionally been hindered by multiple factors, including the complexity of the brain itself. As a result, brain treatments remain insufficient and research is disproportionately underfunded compared to other disease areas.   

We believe enhanced multi-stakeholder engagement in the brain ecosystem is needed to foster dialogue, exchange knowledge, accelerate investment in research and innovation, facilitate business development and showcase on-going work. 

The Brain Innovation Days were shaped through the notion that multi-stakeholder engagement in the brain community is key to drive progress and foster innovation. Though the community at large has improved in collaboration, it is oft still fragmented and siloed; the Brain Innovation Days want to help change this and reshape the brain ecosystem to one that supports its members, pushes for knowledge exchange for the greater good, stimulates investment and convinces key stakeholders that the future is in brain innovation. 

For more information: 

Visit the website braininnovationdays.eu
Follow us on Twitter and LinkedIn
Email info@braininnovationdays.eu  

The post The Brain Innovation Days kick off today: a 1-year journey to discover the future of brain research appeared first on European Brain Council (EBC).

In this context, EBC hosted two side sessions, on the topic of “The Potentials of Increased Collaboration in Science: examples from the brain community” exploring how global research collaboration can support brain research in a meaningful way, to the benefit of patients across the globe. The second session that EBC coorganised with the European Federation of the Neurological Associations (EFNA) and the European Academy of Neurology (EAN) was entitled “Do the SDGs address the global burden of disease? A focus on regional health and research policies”. This session highlighted the importance of an integrated and all-encompassing approach to brain health.

“The Potentials of Increased Collaboration in Science: examples from the brain community“

Prof Wolfgang H. Oertel, EBC Vice President, introduced the first session on “The potentials of Increased Collaboration in Science” which featured several video messages from a prominent line-up of speakers:

• Mr Carlos Morais Pires, Cabinet Member of Commissioner Mariya Gabriel;
• Prof. Tracy Bale, President of the International Brain Research Organization (IBRO);
• Prof Carmen Sandi, President of the Federation of European Neuroscience Societies;
• Dr Walter J. Koroshetz, Director of the National Institute of Neurological Disorders and Stroke of the U.S. National Institutes of Health;
• Prof Barry Everitt, President of the Society for Neuroscience;
  
• Mr Linhao Chen, Deputy Director General of International Cooperation within the Ministry of Science and Technology in China;
• Mr Quan Zhang, Director of Science and Technology Commission of Shanghai Municipality,
• Professor Linda J. Richards, Head of the Brain development and disorders laboratory (Queensland Brain Institute); Co-Chair of the Australian Brain Alliance and Spokesperson of International Brain Initiative;
• Prof Amadi O. Ihunwo, Secretary General and CEO of the Society of Neuroscientists of Africa (SONA);
• Prof Foad Abd-Allah, Vice-President of the African Academy of Neurology;
• Prof. Mohamed Hassan, President of the World Academy of Sciences
• Dr Caroline Montojo, from the Kavli Foundation and International Brain Initiative.

All the international guests shared their visions from a different point of view on the role of international cooperation in the constant progress of brain research.

A panel discussion between Prof Monica Di Luca, EBC President, Dr Tomás Ryan, Chair of the FENS-Kavli Network and Prof Mu-ming Poo, Founding Director of the Institute of Neuroscience (ION) of the Chinese Academy of Sciences followed after the presentations. During a live Q&A with the audience, the panelists responded to stimulating and thought-provoking questions raised by the participants.

“Do the SDGs address the global burden of disease? A focus on regional health and research policies”

The second session exploring how the SDGs address the global burden of disease stressed the need to make the brain disorders, neurological and mental alike, the political priority. Frédéric Destrebecq, EBC Executive Director had the pleasure to moderate the session and Joke Jaarsma, President of the European Federation of the Neurological Associations (EFNA) and EBC Treasurer, gave an insightful introduction in which she acknowledged an addition of mental health and neurological disorders to list of priority NCDs (noncommunicable diseases).

After a word of welcome, Prof. Valery L Feigin (National Institute for Stroke and Applied Neurosciences) had a presentation on global burden of disease with a particular focus on neurology including key priorities and recommendations. After that, Tarun Dua, Head of the Brain Health Unit (Department of Mental Health and Substance Use, WHO) highlighted the importance of more high-level strategic linkages between work on non-communicable diseases, sustainable development goals and the universal health coverage. Dr Samuel Wiebe, President of the International League Against Epilepsy and the Director of the Clinical Research Unit Cumming School of Medicine (University of Calgary) presented afterwards epilepsy as a case study emphasizing the current challenges and the opportunities for action at a global level. Last but not least, Prof. Valery L Feigin (National Institute for Stroke and Applied Neurosciences, Auckland University of Technology) provided some interesting insights on how free mobile digital technology can reduce the global burden of stroke.

Finally, the session was closed by a fruitful and interactive discussion on the importance of the multidisciplinary and multisectoral approach. After a stimulating exchange, the speakers replied to all the questions of the public during a live Q&A.

The post Event report: EBC Sessions at Digitalscience@UNGA75 appeared first on European Brain Council (EBC).